期刊文献+

经内外括约肌间切除术治疗超低位直肠癌23例分析 被引量:6

Treatment of intersphincteric resection for ultra low rectal tumor:an analysis of 23 cases
原文传递
导出
摘要 目的探讨经内外括约肌间切除术(intersphincteric resection,ISR)治疗超低位直肠癌的应用价值。方法2005年3月至2007年3月四川省人民医院普外三科对23例病灶下缘距离齿状线≤2cm的超低位直肠癌进行术前评估,行ISR,其中5例进展期直肠癌术前行新辅助化疗。结果全组无手术死亡,平均随访24个月,均未发现局部复发,1例出现远处肝转移,所有病人术后6个月至1年肛门功能恢复满意。结论ISR是一种可选择的治疗超低位直肠癌的根治性保肛方法。 Objective To explore the effect of intersphincteric resection (ISR) as the sphincter-saving procedure for ultra low rectal tumor. Methods From March 2005 to March 2007, 23 ultra low rectal tumor patients whose distal tumor edges were no more than 2em from the dentate line were evaluated preoperatively. All of them were underwent ISR. Five patients with advanced rectal cancer received preoperative chemo-radiation. Results There was no pefioperative death. The average time of follow-up was 24 months. Twenty-three patients showed no evidence of local recurrence. They were satisfied with their fecal control after 6 months. Conclusion ISR is an alternative sphincter-saving procedure for the radical resection of ultra low rectal tumor.
出处 《中国实用外科杂志》 CSCD 北大核心 2009年第2期158-159,共2页 Chinese Journal of Practical Surgery
关键词 经内外括约肌间切除 直肠癌 保肛手术 intersphincteric resection rectal cancer sphincter-saving procedure
  • 相关文献

参考文献6

二级参考文献46

  • 1刘宝华,程雪云.肛肠肌电图对直肠癌术后肛门功能评价[J].中国肛肠病杂志,1996,16(2):22-24. 被引量:15
  • 2Chih-ChienChin,Wen-ShihHuang,Jeng-YiWang,Chien-Yuh Yeh.Clinical outcome of intersphincteric resection for ultra-low rectal cancer[J].World Journal of Gastroenterology,2006,12(4):640-643. 被引量:19
  • 3Marks J,Karachristes A,Marks G,et al.Neoadjurant therapy in rectal cancer patients peraits conversion from permanent colostomy to sphineter-preservation surgery.Proc ASCO,2002 21:168a,Abst 670.
  • 4Wong SJ,Sadasiwan C,Erickson B,et al.A phase Ⅱ trial of preoperative capecitabine and concurrent radiation for locally advanced rectal cancer.Proc ASCO,2004,23:312,Abst 3771.
  • 5Gunderson LL,Sargent DJ,Tepper JE,et al.Impact of T and N stage and treatment on Survival and relapse in adjuvant cancer:A pooled analysis.J Clin Oncot,2004,22(10):1785-1796.
  • 6Roh MS,Colangelo L,asieand S,et al.Response to preoperative multimodality therapy predicts survival in patients with carcinoma of the rectum.Proc ASCO,2004,23:247,Abst 3505.
  • 7Dupuic O,Vie B LIdeo G,et al.Capecitabine (X) chemoradiation(CRT) in the preoperative treatment of patients (pts) with rectal adenocarcinoma:A phase Ⅱ GERCOR Trial.Proc ASCO,2004,23:255,Abst 3538.
  • 8De Paoli A,Chiara S,Luppi G,et al.A phase Ⅱ study of capecitabline (CAP) and preoperative radiation therapy(RT)in reseatable locally advanced rectal cancer (LARC).Proc ASCO,2004,23:255,Abst 3540.
  • 9Mitchell EP,Winter K,Mohiuddin M,et al.Randomiged phase Ⅱ trail of preoperative combined modality chemoradiation for distal rectal cancer.Proc ASCO,2004,23:254,Abst 3535.
  • 10Scott N,Jackson P,Al-Jaberi T,et al.Total mesorectal excision and local recurrence:a study of lumor spread in the mesorectum distal to rectal cancer.Br J Surg,1995,82:1031-1033.

共引文献102

同被引文献62

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部